Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AbCellera Biologics Inc (ABCL) vs United States Brent Oil Fund LP (BNO) Price & Performance

AbCellera Biologics IncTrade
United States Brent Oil Fund LPTrade

Price performance (Past 24H)

Key statistics

AbCellera Biologics Inc vs United States Brent Oil Fund LP — how do they compare? AbCellera Biologics Inc trades at $9.04 (market cap $2.85B), while United States Brent Oil Fund LP trades at $51.06. The key difference: AbCellera Biologics Inc is trading nearer its 52-week high, United States Brent Oil Fund LP nearer its low. Which is the better fit depends on your goals.

ABCLBNO
Market Cap
$2.85B
Sector
HealthCommodities - Energy
52-Week High
$9.76$60.13
52-Week Low
$2.78$27.20
Enterprise Value
$2.45B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

AbCellera Biologics Inc

ABCL's stock surged 6.13% to $6.93, driven by positive Phase 2 trial results for its menopause drug ABCL635, which showed an 83% reduction in hot flashes. Despite a bullish technical signal and strong analyst consensus (91.67% buy ratings), the company faces fundamental challenges with a net income margin of -248.84% and negative cash flow from operations. Revenue declined from $485M in 2022 to $75M in 2025, though recent news highlights potential from clinical advancements and a collaboration with Vertex.

The outlook is mixed: near-term optimism hinges on drug development success, but high valuation ratios (P/S of 31.63) and persistent losses pose risks. Investors should weigh the 54% upside to the $10.67 price target against cash burn and competitive pressures in biotech.

United States Brent Oil Fund LP

BNO, a US-listed exchange-traded product tracking Brent crude oil futures, trades at $46.93, down 0.93% amid bearish technical signals. The overall technical outlook is bearish, with moving averages indicating selling pressure, while oscillators remain neutral. Recent news highlights Middle East tensions, particularly the deadlock over the Strait of Hormuz, influencing oil price volatility and investor sentiment.

The outlook for BNO is heavily tied to geopolitical developments and oil supply dynamics. Risks include prolonged Middle East instability and oil price corrections, but potential supply disruptions could offer upside. Investors should monitor OPEC decisions and US-Iran negotiations for directional cues, as these factors drive near-term performance.

Returns comparison

Trailing returns across standard periods

About AbCellera Biologics Inc

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.

Read more on ABCL

About United States Brent Oil Fund LP

BNO is a commodity ETF that tracks the daily price of Brent crude oil futures. It provides exposure to the international oil benchmark, which often trades at a premium to the U.S. WTI benchmark, and is primarily used for short-term trading due to roll costs.

Read more on BNO